Work

Naringenin ameliorates PCOS-associated miscarriage by targeting C/EBPβ to suppress decidual macrophage pyroptosis

Year: 2026
Type: article
Abstract: To determine whether naringenin ameliorates PCOS-associated miscarriage by targeting C/EBPβ-dependent decidual macrophage pyroptosis. Methods: DHEA-induced PCOS mice and an in vitro macrophage pyroptosis model were used. Transcriptomic profiling, PELSA-based target identification, molecular docking, molecular dynamics simulations, ChIP-qPCR, and gain-/loss-of-function experiments were performed. Results: Naringenin reduced embryo resorption and restored decidual homeostasis in PCOS mice. Transcriptomics identified macrophage pyroptosis via NLRP3/AIM2–caspase-1–GSDMD activation as a key pathological feature of PCOS decidua, which naringenin attenuated in vivo and in vitro. PELSA combined with structural validation identified C/EBPβ as a molecular target of naringenin. Pharmacological C/EBPβ inhibition attenuated pyroptosis, whereas C/EBPβ overexpression diminished naringenin's protection. Mechanistically, naringenin reduced C/EBPβ occupancy at Aim2, IL18, and IL1β promoters, suppressing inflammasome transcriptional activation. Naringenin ameliorates PCOS-associated miscarriage by targeting C/EBPβ, thereby suppressing inflammasome activation and decidual macrophage pyroptosis.
Source: iScience
Language: English
Open Access status: gold
Estimated APC paid: $3,240
OpenAlex ID: W7236774102
FWCI:
Cites: 46
Cited by:
Related to: 10